Stay updated on IMP321 for Advanced Solid Tumors Clinical Trial.

Sign up to get notified when there's something new on the IMP321 for Advanced Solid Tumors Clinical Trial. page.
Latest website image capture
Clouds background image

Latest updates to the IMP321 for Advanced Solid Tumors Clinical Trial. page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.3%
    Check dated 2025-04-30T06:37:59.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.4 to v2.15.0, indicating a significant revision. The phrase 'Here’s how you know' has been removed and replaced with a similar phrase.
    Difference
    1.0%
    Check dated 2025-04-15T20:46:25.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 13, 2025. However, the removal of the date March 25, 2025, does not significantly impact the core content.
    Difference
    1.0%
    Check dated 2025-04-08T17:10:40.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    5%
    Check dated 2025-02-24T13:27:46.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    The page has updated the date related to the feasibility and safety study of IMP321 (eftilagimod Alpha) for advanced stage solid tumors, changing it from November 7, 2024, to February 13, 2025.
    Difference
    1%
    Check dated 2025-02-17T12:32:12.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    6%
    Check dated 2025-02-10T08:49:18.000Z thumbnail image

Stay in the know with updates to IMP321 for Advanced Solid Tumors Clinical Trial.

Enter your email address, and we'll notify you when there's something new on the IMP321 for Advanced Solid Tumors Clinical Trial. page.